Ankit Kansagra, Associate Vice President Oncology Integration and Community Alliance at Tampa General Hospital, Adjunct Professor at UT Southwestern Medical Center, shared on LinkedIn:
“Mark your calendars for August 29th!
I’m looking forward to joining colleagues at the FLASCO COS: Malignant Heme 2026 meeting in Tampa.
As part of the program, I’ll be going head-to-head with my colleague Nina Nguyen in a debate covering the role of CAR-T in Multiple Myeloma. The data and treatment paradigms in this space are shifting incredibly fast, and I’m excited to dive deeply into the nuances of how we sequence and apply these therapies.
Check out the link below to register. Hope to see many of you there for a great discussion!”
Other articles about Multiple Myeloma and CAR-T on OncoDaily.
